Luc F. Van Gaal
Department of Endocrinology
Diabetology and Metabolism
Antwerp University Hospital
University of Antwerp
Belgium
Name/email consistency: high
- Bariatric surgery to treat type 2 diabetes: what is the recent evidence? Van Gaal, L.F., De Block, C.E. Curr. Opin. Endocrinol. Diabetes. Obes (2012)
- Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial. Van Gaal, L.F., Caterson, I.D., Coutinho, W., Finer, N., Maggioni, A.P., Sharma, A.M., Torp-Pedersen, C., Ge, H., Moran, S.A., Shepherd, G.M., James, W.P. Diabetes. Obes. Metab (2010)
- Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study. Van Gaal, L.F., Scheen, A.J., Rissanen, A.M., Rössner, S., Hanotin, C., Ziegler, O. Eur. Heart J. (2008)
- Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Van Gaal, L., Pi-Sunyer, X., Després, J.P., McCarthy, C., Scheen, A. Diabetes. Care (2008)
- Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control? Van Gaal, L.F., Gutkin, S.W., Nauck, M.A. Eur. J. Endocrinol. (2008)
- Reducing cardiometabolic risk through selective antagonism of CB1 receptors. Van Gaal, L. Clin. Cornerstone (2007)
- Mechanisms linking obesity with cardiovascular disease. Van Gaal, L.F., Mertens, I.L., De Block, C.E. Nature (2006)
- New approaches for the management of patients with multiple cardiometabolic risk factors. Van Gaal, L.F., Peiffer, F. J. Endocrinol. Invest. (2006)
- Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity. Van Gaal, L.F. Eur. Neuropsychopharmacol (2006)
- Modern, new pharmacotherapy for obesity. A gastrointestinal approach. Van Gaal, L., Mertens, I., Ballaux, D., Verkade, H.J. Best. Pract. Res. Clin. Gastroenterol (2004)
- Rationale and options for combination therapy in the treatment of Type 2 diabetes. Van Gaal, L.F., De Leeuw, I.H. Diabetologia (2003)
- The importance of obesity in diabetes and its treatment with sibutramine. Van Gaal, L.F., Peiffer, F.W. Int. J. Obes. Relat. Metab. Disord. (2001)